These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2230260)

  • 41. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis.
    Lefèvre JC; Escaffre MC; Courdil M; Lareng MB
    Pathol Biol (Paris); 1993 Apr; 41(4):313-5. PubMed ID: 8233628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chlamydia trachomatis infection in women.
    Faro S
    J Reprod Med; 1985 Mar; 30(3 Suppl):273-8. PubMed ID: 4020784
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro tetracycline susceptibility of Chlamydia trachomatis in clinical specimens.
    Hsu AH; Knelsen B; Kasatiya S
    Antonie Van Leeuwenhoek; 1987; 53(3):191-6. PubMed ID: 3662489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chlamydia and urogenital chlamydioses (a review of the literature)].
    Il'in II
    Voen Med Zh; 1986 Apr; (4):27-31. PubMed ID: 3523978
    [No Abstract]   [Full Text] [Related]  

  • 45. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.
    Nuovo J; Melnikow J; Paliescheskey M; King J; Mowers R
    J Am Board Fam Pract; 1995; 8(1):7-16. PubMed ID: 7701965
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-dose minocycline in the treatment of gonococcal urethritis. Clinical efficacy in relation to bacterial resistance and its effects on associated Chlamydia trachomatis infections.
    Waterworth PM; Oriel JD; Ridgway GL; Subramanian S
    Br J Vener Dis; 1979 Oct; 55(5):343-7. PubMed ID: 116707
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis.
    Deguchi T; Hatazaki K; Ito S; Kondo H; Horie K; Nakane K; Mizutani K; Tsuchiya T; Yasuda M; Yokoi S; Nakano M
    J Infect Chemother; 2018 Aug; 24(8):610-614. PubMed ID: 29627327
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in HIV-seropositive patients and gonococcal antimicrobial susceptibility: an update in Thailand.
    Srifeungfung S; Roongpisuthipong A; Asavapiriyanont S; Lolekha R; Tribuddharat C; Lokpichart S; Sungthong P; Tongtep P
    Jpn J Infect Dis; 2009 Nov; 62(6):467-70. PubMed ID: 19934542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activity of ofloxacin against Chlamydia trachomatis.
    Schachter J; Moncada JV
    Am J Med; 1989 Dec; 87(6C):14S-16S. PubMed ID: 2690615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Chlamydia trachomatis infection in men and its association with gynecologic alterations in their sexual partners].
    Guerra-Infante FM; Tapia-Yáñez JR; López-Hurtado M; Flores-Medina S; Díaz-García FJ
    Rev Invest Clin; 2005; 57(3):406-14. PubMed ID: 16187700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The role of Chlamydia trachomatis infections in women with urinary tract diseases].
    Zdrodowska-Stefanow B; Darewicz B; Ostaszewska I; Puciło K
    Pol Merkur Lekarski; 1997 Apr; 2(10):270-2. PubMed ID: 9377664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of sustained antibiotic bactericidal treatment on Chlamydia trachomatis-infected epithelial-like cells (HeLa) and monocyte-like cells (THP-1 and U-937).
    Mpiga P; Ravaoarinoro M
    Int J Antimicrob Agents; 2006 Apr; 27(4):316-24. PubMed ID: 16527461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chlamydia trachomatis: in vitro susceptibility to antibiotics singly and in combination.
    Christensen JJ; Holten-Andersen W; Nielsen PB
    Acta Pathol Microbiol Immunol Scand B; 1986 Oct; 94(5):329-32. PubMed ID: 3788573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotic susceptibility of alpha- and nonhemolytic streptococci from patients and healthy adults to 24 antimicrobial drugs.
    Traub WH; Leonhard B
    Chemotherapy; 1997; 43(2):123-31. PubMed ID: 9084921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro.
    Dreses-Werringloer U; Padubrin I; Zeidler H; Köhler L
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3001-8. PubMed ID: 11600348
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of dirithromycin against Chlamydia trachomatis.
    Segreti J; Kapell KS
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2213-4. PubMed ID: 7811051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chlamydia trachomatis in women: the more you look, the more you find.
    Hay PE; Thomas BJ; Horner PJ; MacLeod E; Renton AM; Taylor-Robinson D
    Genitourin Med; 1994 Apr; 70(2):97-100. PubMed ID: 8206484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of minimal inhibitory concentration (MIC) and minimal lethal concentration (MLC) values for tetracycline, monocycline, erythromycin and rokitamycin against eleven strains of Chlamydia trachomatis].
    Bianchi A; Scieux C; Robache S; Vassias I; Pérol Y
    Pathol Biol (Paris); 1991 May; 39(5):442-5. PubMed ID: 1881673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry.
    Dessus-Babus S; Belloc F; Bébéar CM; Poutiers F; Lacombe F; Bébéar C; de Barbeyrac B
    Cytometry; 1998 Jan; 31(1):37-44. PubMed ID: 9450523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence.
    Bailey JM; Heppleston C; Richmond SJ
    Antimicrob Agents Chemother; 1984 Jul; 26(1):13-6. PubMed ID: 6383207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.